| |
 |
|
Class Information
Number: 514/26
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > O-glycoside > Cyclopentanohydrophenanthrene ring system
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7538093 |
Compositions and methods for therapeutic use |
May. 26, 2009 |
| 7534768 |
Treatment of DNA viral infections |
May. 19, 2009 |
| 7534769 |
Compositions and methods for enhancing delivery of therapeutic agents to cells |
May. 19, 2009 |
| 7534770 |
Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
May. 19, 2009 |
| 7531520 |
Drug and food or drink for improving pancreatic functions |
May. 12, 2009 |
| 7507720 |
5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
Mar. 24, 2009 |
| 7387805 |
Flavonoid solubilizion agent and method of solubilizing flavonoid |
Jun. 17, 2008 |
| 7368137 |
Smilagenin and its use |
May. 6, 2008 |
| 7323452 |
Method for the accelerated in vivo removal of ethanol |
Jan. 29, 2008 |
| 7179455 |
Pesticide in gel form |
Feb. 20, 2007 |
| 7163702 |
Process for isolating sea cucumber saponin Frondoside A, and immunomodulatory methods of use |
Jan. 16, 2007 |
| 7160866 |
Isolation of tigogenin pentaglycoside from Chlorophytum nimonii |
Jan. 9, 2007 |
| 7153877 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
Dec. 26, 2006 |
| 7119110 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
Oct. 10, 2006 |
| 7115586 |
Non-inclusion cyclodextrin complexes |
Oct. 3, 2006 |
| 7109175 |
Specific steady-state R-type CA.sup.2+ channel blockers and use thereof |
Sep. 19, 2006 |
| 7101857 |
Crosslinkable biological material and medical uses |
Sep. 5, 2006 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 7091187 |
Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
Aug. 15, 2006 |
| 7030094 |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
Apr. 18, 2006 |
| 7015202 |
Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
Mar. 21, 2006 |
| 7008929 |
Sapogenin-based treatment |
Mar. 7, 2006 |
| 7001893 |
Inclusion complex of Rifampicin, an anti-tubercular drug, with .beta.-cyclodextrin or 2-hydroxypropyl .beta.-cyclodextrin and a process thereof |
Feb. 21, 2006 |
| 6992068 |
Cytokine production inhibitors, agents for protecting and promoting liver function, anti-inflammatory agents, immunosuppressants, drugs, cosmetics, foods and food materials |
Jan. 31, 2006 |
| 6930093 |
Use of ribofuranose derivatives against inflammatory bowel diseases |
Aug. 16, 2005 |
| 6916791 |
Androgen derivatives and uses thereof |
Jul. 12, 2005 |
| 6894030 |
Treatment of DNA viral infections |
May. 17, 2005 |
| 6887853 |
Use of geldanamycin and related compounds for treatment of fibrogenic disorders |
May. 3, 2005 |
| 6867194 |
Enzyme activated nitric oxide donors |
Mar. 15, 2005 |
| 6861410 |
Immunological adjuvant compositions |
Mar. 1, 2005 |
| 6844322 |
Method for induced lactation |
Jan. 18, 2005 |
| 6835715 |
Mammalian dihydroouabain-like factor and therapeutic compositions |
Dec. 28, 2004 |
| 6833362 |
Method and composition for the accelerated in vivo removal of ethanol |
Dec. 21, 2004 |
| 6818624 |
Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food |
Nov. 16, 2004 |
| 6812213 |
Steroidal sapogenins and their derivatives for treating alzheimer's disease |
Nov. 2, 2004 |
| 6812214 |
Use of harpagid-related compounds for prevention and treatment of osteoporosis, arthritis and ruptured disc and pharmaceutical composition containing the same |
Nov. 2, 2004 |
| 6784160 |
Biologically active pregnene compounds |
Aug. 31, 2004 |
| 6784159 |
Triterpene saponins from soybeans for treating kidney disease |
Aug. 31, 2004 |
| 6720307 |
Glycosylated analogs of fusidic acid |
Apr. 13, 2004 |
| 6713074 |
Cosmetic composition and method |
Mar. 30, 2004 |
| 6699676 |
Uses of ouabain and ouabain-like molecules in apoptosis related pathologies |
Mar. 2, 2004 |
| 6670369 |
Use of phanquinone for the treatment of alzheimer's disease |
Dec. 30, 2003 |
| 6670348 |
Methods and compositions for destruction of selected proteins |
Dec. 30, 2003 |
| 6664232 |
HLA-A2 restraint tumor antigen peptide originating in SART-1 |
Dec. 16, 2003 |
| 6630453 |
Androgen derivatives and uses thereof |
Oct. 7, 2003 |
| 6593301 |
Use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds |
Jul. 15, 2003 |
| 6579853 |
Brain cell or nerve cell-protective agents comprising ginsenoside Rb1 |
Jun. 17, 2003 |
| 6538027 |
Compositions comprising ratite oil or active fractions thereof and methods of using these composition as insect repellents |
Mar. 25, 2003 |
| 6528058 |
Saponin adjuvant composition |
Mar. 4, 2003 |
| 6518319 |
Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms |
Feb. 11, 2003 |
|
|
|
